These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15105402

  • 1. Embryo quality in natural versus stimulated IVF cycles.
    Ziebe S, Bangsbøll S, Schmidt KL, Loft A, Lindhard A, Nyboe Andersen A.
    Hum Reprod; 2004 Jun; 19(6):1457-60. PubMed ID: 15105402
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 3. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH.
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P.
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [Abstract] [Full Text] [Related]

  • 6. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G, Agirregoikoa JA, Jiménez MR, de Larruzea AL, Ganzabal T, Carbonero K.
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.
    Andersen AN, Devroey P, Arce JC.
    Hum Reprod; 2006 Dec; 21(12):3217-27. PubMed ID: 16873892
    [Abstract] [Full Text] [Related]

  • 9. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P.
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [Abstract] [Full Text] [Related]

  • 10. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
    Chen QJ, Sun XX, Li L, Gao XH, Wu Y, Gemzell-Danielsson K, Cheng LN.
    Acta Obstet Gynecol Scand; 2007 Jun; 86(7):849-54. PubMed ID: 17611831
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 12. Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer.
    Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J, Uzan S.
    Fertil Steril; 2004 Jul; 82(1):119-25. PubMed ID: 15236999
    [Abstract] [Full Text] [Related]

  • 13. Inadvertent recombinant human follicle stimulating hormone bolus instead of human chorionic gonadotrophin leads to the retrieval of competent oocytes in IVF program.
    Bianchi V, Dal Prato L, Maccolini A, Mazzone S, Borini A.
    Fertil Steril; 2009 Nov; 92(5):1747.e1-3. PubMed ID: 19732874
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [Abstract] [Full Text] [Related]

  • 15. Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles.
    Lee JR, Choi YS, Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH.
    Fertil Steril; 2007 Nov; 88(5):1344-9. PubMed ID: 17548083
    [Abstract] [Full Text] [Related]

  • 16. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C.
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [Abstract] [Full Text] [Related]

  • 17. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
    Qublan HS, Amarin Z, Tahat YA, Smadi AZ, Kilani M.
    Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
    [Abstract] [Full Text] [Related]

  • 18. Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?
    Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2004 Nov; 19(11):2550-4. PubMed ID: 15298978
    [Abstract] [Full Text] [Related]

  • 19. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
    Kdous M, Chaker A, Zhioua A, Zhioua F.
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
    [Abstract] [Full Text] [Related]

  • 20. [GnRH antagonists in natural cycles].
    Frydman R.
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S46-9. PubMed ID: 15643689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.